Hu, Jiong
Dziumbla, Sarah
Lin, Jihong
Bibli, Sofia-Iris
Zukunft, Sven
de Mos, Julian
Awwad, Khader
Frömel, Timo
Jungmann, Andreas
Devraj, Kavi
Cheng, Zhixing
Wang, Liya
Fauser, Sascha
Eberhart, Charles G.
Sodhi, Akrit
Hammock, Bruce D.
Liebner, Stefan
Müller, Oliver J.
Glaubitz, Clemens
Hammes, Hans-Peter
Popp, Rüdiger
Fleming, Ingrid
Article History
Received: 23 May 2016
Accepted: 9 November 2017
First Online: 6 December 2017
Competing interests
: J.H., T.F., R.P. and I.F. are authors of patent applications for the use of sEH inhibitors in the treatment of non-proliferative diabetic retinopathy (German Patent Application no. 10 2016 109 709.8, International PCT Patent Application no. PCT/EP2017/062618). S.F. is an employee of F. Hoffmann-La Roche Ltd, Basel, Switzerland. B.D.H. is author of the University of California patents on sEH inhibitors licensed to EicOsis. None of the other authors has any disclosures to declare.